Latest filing published 07 Oct 2026 for Moderna, Inc.. Read the official filing
This profile gathers the share dealings of James M. Mock across 2 companies, led by Moderna, Inc. and Revvity, Inc. Between 15 May 2018 and 5 October 2026, the trades on record add up to 60 filings.
The open-market record consists of 7 sales worth €5.1M, with no purchase. Besides market trades, the filings include 19 share grants and 34 option exercises. 2026 to date brings no purchases and 2 sales.
The newest entry dates from 7 October 2026: an option exercise, in Moderna, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 50 declarations